Lifevantage Corp
LFVNNasdaq
$6.20
↑ +0.3%Jul 17 close · end-of-day
Price
1Y↓ -49.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$78.5M
Enterprise Value
$78.5M
P/E
13.5
P/S
0.4
P/B
2.4
EV/EBITDA
8.3
PEG
0.3
FCF Yield
4.8%
Dividend Yield
2.9%
Revenue (TTM)
$195.3M
Net Income (TTM)
$5.8M
Free Cash Flow (TTM)
$3.8M
Gross Margin
78.1%
Operating Margin
3.4%
Net Margin
2.9%
ROE
17.3%
ROIC
16.8%
Debt / Equity
—
Net Cash
—
Return 1Y
-52.2%
Company profile
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, and Singapore.
- CEO
- Steven R. Fife
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 260
- Headquarters
- Utah
- Website
- lifevantage.com
Management & directors
- Aure CarlChief Financial Officer
- Cunningham KristenChief Sales Officer
- Neufeld AlissaGeneral Counsel
- Fife Steven RPresident and CEO
- Thompson ToddChief Information Officer
- Boyster JulieChief Marketing Officer
Roles derived from SEC Form 4 filings.
Earnings
LFVN Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$43.7M↓ -25.2%
Diluted EPS$0.11↓ -57.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $220.2M | $206.4M | $213.4M | $200.2M | $228.5M |
| Gross profit | $182.0M | $168.3M | $170.0M | $158.7M | $183.7M |
| Operating income | $17.6M | $7.6M | $4.3M | $4.3M | $12.2M |
| Net income | $12.9M | $3.1M | $2.5M | $2.9M | $9.8M |
| Diluted EPS | $0.90 | $0.24 | $0.20 | $0.23 | $0.75 |
| Operating cash flow | $16.3M | $8.0M | $6.8M | $12.2M | $11.9M |
| Free cash flow | $12.5M | $6.4M | $3.8M | $10.0M | $10.5M |
| Gross margin | 82.7% | 81.5% | 79.7% | 79.3% | 80.4% |
| Operating margin | 8.0% | 3.7% | 2.0% | 2.2% | 5.3% |
| Net margin | 5.9% | 1.5% | 1.2% | 1.5% | 4.3% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.9M | $47.2M | $67.8M | $58.4M | $55.1M | $47.6M | $48.9M | $43.7M |
| Gross profit | $38.9M | $37.7M | $54.6M | $47.3M | $44.0M | $37.8M | $36.2M | $34.5M |
| Operating income | $2.9M | $2.6M | $3.4M | $4.1M | $2.1M | $2.3M | $487,000.00 | $1.7M |
| Net income | $1.3M | $1.8M | $2.5M | $3.5M | $2.0M | $2.2M | $276,000.00 | $1.4M |
| Diluted EPS | $0.10 | $0.14 | $0.19 | $0.26 | $0.16 | $0.17 | $0.02 | $0.11 |
| Operating cash flow | $2.6M | -$583,000.00 | $9.2M | $2.2M | $1.0M | -$2.3M | $2.8M | $5.0M |
| Free cash flow | $2.3M | -$932,000.00 | $8.7M | $1.9M | $835,000.00 | -$2.7M | $1.7M | $4.0M |
| Gross margin | 79.5% | 79.9% | 80.5% | 81.0% | 79.9% | 79.5% | 74.0% | 79.0% |
| Operating margin | 5.9% | 5.4% | 5.1% | 6.9% | 3.9% | 4.8% | 1.0% | 3.8% |
| Net margin | 2.7% | 3.9% | 3.8% | 5.9% | 3.6% | 4.5% | 0.6% | 3.1% |
Company news
May 28, 2026
May 27, 2026
May 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Cunningham Kristen· Chief Sales Officer | Tax withholding | 1,717 | $6.25 | $10,731.25 | filing |
| 2026-07-01 | Aure Carl· Chief Financial Officer | Tax withholding | 1,361 | $6.25 | $8,506.25 | filing |
| 2026-07-01 | Neufeld Alissa· General Counsel | Tax withholding | 1,342 | $6.25 | $8,387.50 | filing |
| 2026-06-15 | Lewis Darwin | Buy | 705 | $8.60 | $6,059.48 | filing |
| 2026-06-03 | BEINDORFF MICHAEL A | Sale | 10,000 | $8.55 | $85,459.00 | filing |
| 2026-04-01 | Fife Steven R· President and CEO | Tax withholding | 8,180 | $4.20 | $34,356.00 | filing |
| 2026-04-01 | Cunningham Kristen· Chief Sales Officer | Tax withholding | 1,928 | $4.20 | $8,097.60 | filing |
| 2026-04-01 | Aure Carl· Chief Financial Officer | Tax withholding | 1,527 | $4.20 | $6,413.40 | filing |
| 2026-04-01 | Neufeld Alissa· General Counsel | Tax withholding | 1,446 | $4.20 | $6,073.20 | filing |
| 2026-03-16 | Lewis Darwin | Buy | 1,055 | $5.23 | $5,517.65 | filing |
| 2026-03-02 | Dayton Judd | Buy | 10,500 | $4.53 | $47,565.00 | filing |
| 2026-02-27 | Dayton Judd | Buy | 18,097 | $4.63 | $83,789.11 | filing |
| 2026-02-26 | Dayton Judd | Buy | 4,600 | $4.58 | $21,068.00 | filing |
| 2026-02-09 | Lewis Darwin | Buy | 3,955 | $5.22 | $20,651.43 | filing |
| 2026-01-01 | Fife Steven R· President and CEO | Tax withholding | 9,169 | $6.16 | $56,481.04 | filing |
| 2026-01-01 | Cunningham Kristen· Chief Sales Officer | Tax withholding | 1,926 | $6.16 | $11,864.16 | filing |
| 2026-01-01 | Aure Carl· Chief Financial Officer | Tax withholding | 1,527 | $6.16 | $9,406.32 | filing |
| 2026-01-01 | Neufeld Alissa· General Counsel | Tax withholding | 1,445 | $6.16 | $8,901.20 | filing |
| 2025-12-23 | Thompson Todd· Chief Information Officer | Tax withholding | 601 | $6.23 | $3,744.23 | filing |
| 2025-12-15 | Lewis Darwin | Buy | 805 | $6.54 | $5,264.62 | filing |
| 2025-11-25 | BEINDORFF MICHAEL A | Gift | 7,819 | $0.00 | $0.00 | filing |
| 2025-11-25 | BEINDORFF MICHAEL A | Gift | 7,819 | $0.00 | $0.00 | filing |
| 2025-11-19 | BEINDORFF MICHAEL A | Sale | 12,607 | $6.42 | $80,934.42 | filing |
| 2025-11-07 | BEINDORFF MICHAEL A | Sale | 35,000 | $6.92 | $242,252.50 | filing |
| 2025-11-07 | BEINDORFF MICHAEL A | Sale | 1,000 | $7.33 | $7,330.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.